World Generic Medicines Congress Americas 2010 (WGMC)
Venue: The Westin Grand Hotel
|Event Date/Time: Nov 16, 2010||End Date/Time: Nov 18, 2010|
|Registration Date: Nov 15, 2010|
|Early Registration Date: Aug 27, 2010|
focuses on the key topics of the day, with input from the industry's most innovative minds. Make sure you are part of this must attend meeting.
Key topics from the industryâ€™s best
Becoming a successful generic player is at the core of most companies in the industry. Robert Wessman, Executive Chairman of Alvogen is focussing on the business model and development strategies to achieve this.
Now it has been passed, what will the Health Care Reform mean for the generics industry? Mylanâ€™s President, Heather Bresch is bringing her unique perspective on these developments and examining how it will impact generic uptake.
Biosimilar medicines present numerous challenges to generic manufacturers. Pascal Brenneison the CEO of Sandoz UK is focusing on the commercial challenges of launching a biosimilar from a generic manufacturers perspective.
Keep generic and biosimilar operations compliant with a global regulatory and policy update from the key policy bodies shaping the industry today with input from Congress and the FTC.
In light of some serious public concerns on the conduct of the drug industry Vikash Salig, CEO of Dr Reddyâ€™s South Africa is asking - what is a reasonable return on investment considering healthcare and enlightened
capitalism in the context of health care delivery?
Hear these key speakers and other leading generic experts address the hot topics of today and the must hear considerations for tomorrowâ€™s market place. Register early and make the most of the huge discounts available
to you and your team.